Parnassus Investments CA trimmed its stake in Perrigo Company PLC (NYSE:PRGO) by 44.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,100,000 shares of the company’s stock after selling 897,500 shares during the period. Parnassus Investments CA’s holdings in Perrigo were worth $42,625,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of PRGO. Atlas Capital Advisors LLC bought a new position in Perrigo in the 4th quarter worth approximately $26,000. NuWave Investment Management LLC increased its position in Perrigo by 17,377.8% in the 3rd quarter. NuWave Investment Management LLC now owns 1,573 shares of the company’s stock worth $111,000 after buying an additional 1,564 shares during the period. Quantamental Technologies LLC bought a new position in Perrigo in the 4th quarter worth approximately $139,000. LS Investment Advisors LLC increased its position in Perrigo by 5.9% in the 4th quarter. LS Investment Advisors LLC now owns 4,317 shares of the company’s stock worth $167,000 after buying an additional 239 shares during the period. Finally, Rehmann Capital Advisory Group increased its position in Perrigo by 8,014.9% in the 3rd quarter. Rehmann Capital Advisory Group now owns 14,120 shares of the company’s stock worth $199,000 after buying an additional 13,946 shares during the period. 85.72% of the stock is currently owned by institutional investors.

Shares of PRGO stock opened at $47.00 on Tuesday. The company has a current ratio of 1.85, a quick ratio of 1.26 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $6.47 billion, a P/E ratio of 9.53, a P/E/G ratio of 1.76 and a beta of 1.31. Perrigo Company PLC has a one year low of $36.28 and a one year high of $90.72.

Several brokerages have commented on PRGO. Royal Bank of Canada set a $50.00 price target on Perrigo and gave the stock a “hold” rating in a research report on Friday, January 4th. Wells Fargo & Co set a $46.00 price objective on Perrigo and gave the company a “hold” rating in a research report on Sunday, December 30th. Morgan Stanley set a $67.00 price objective on Perrigo and gave the company a “hold” rating in a research report on Sunday, December 30th. Leerink Swann lowered their price objective on Perrigo from $70.00 to $56.00 in a research report on Monday, December 24th. Finally, Cantor Fitzgerald set a $107.00 price objective on Perrigo and gave the company a “buy prgo” rating in a research report on Thursday, December 20th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the stock. Perrigo presently has a consensus rating of “Hold” and an average target price of $77.36.

ILLEGAL ACTIVITY NOTICE: This piece was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.dailypolitical.com/2019/02/12/perrigo-company-plc-prgo-position-decreased-by-parnassus-investments-ca.html.

Perrigo Company Profile

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

See Also: Consumer Price Index (CPI)

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company PLC (NYSE:PRGO).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.